GCGJ — GUOCHUN INTERNATIONAL INC.

OTC · Information Technology · IT Services · CIK 1765048 ·
Last close
Market Cap
52W High
52W Low
ADV30
Next earnings
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Dec 2024 0 0 -6,844 -6,844 0 54,612
Dec 2023 0 0 -6,194 -6,194 0 28,027
Dec 2022 0 0 -2,163 -7,365 0 5,080
Dec 2021 0 0 -2,678 -5,552 1,075 1,075 45,328

Annual Trend (SEC EDGAR, last 6y)

Revenues vs Net Income (last 6y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Dec 2023 0 -22,947 -22,947 0 28,027
Dec 2022 0 -16,619 -16,619 0 5,080
Dec 2021 0 -31,619 -31,619 1,075 45,328
Dec 2020 0 -23,952 -23,952 1,432 14,066
Dec 2019 0 -11,575 -23,952 196 -10,407
Dec 2018 0 -1,832 -1,832 3,226 3,226

TTM Snapshot

Revenues TTM
$0
NetIncome TTM
$-25,955
OpCashFlow TTM
$0
Assets (Latest)
$0
Forward EPS

Peers — same industry

TickerNameMarket CapLastDaily %
GOOGL Alphabet Inc. $2.11T $359.68
META Meta Platforms, Inc. $1.25T $566.98
APP AppLovin Corp $151.88B $496.77
ADP AUTOMATIC DATA PROCESSING INC $90.42B $226.21
NBIS Nebius Group N.V. $51.21B $232.36

Recent Insider Activity

No insider activity indexed for this ticker.